Table 2.
Reference | Year | Randomized | No. in Intervention/Control Group |
Type of Cryotherapy | Duration of Cryotherapy | Chemo Regimen | Mucositis Staging | Intervention Group | Control Group |
---|---|---|---|---|---|---|---|---|---|
Dumontet15 | 1994 | No | 22/− | Ice chips + cold water | 5 min pre melphalan and continued for 30 min |
Mel or BEAM ±TBI | WHO, Grade 3-4 | TBI: 86% No TBI: 33% |
|
Meloni16 | 1996 | No | 18/− | Ice popsicles | 5 min pre, during, and 5 after melphalan infusion |
Mel or BEAM | WHO, Grade 4 | 6% | |
Aisa33 | 2005 | No | 18/7 (historical control) |
Ice chips + cold water | 15 min pre and during, until 90 min after melphalan infusion |
Mel + Flu ± Other1 | CTC, Grade 2-3 | 11% | 86% |
Mori36 | 2006 | No | 17/18b | Ice chips + cold water | 15 min pre and during, until 60 or 90 min after melphalan infusion |
Mel + Flu ± Othera | CTC, Grade 2-3 | 60 min: 11.8% 120 min: 11.1% |
- |
Lilleby35 | 2006 | Yes | 21/20 | Ice chips | 30 min pre and during, until 6 hours after infusion |
Mel | CTC, Grade 3-4 | 14% | 74% |
Svanberg37 | 2007 | Yes | 39/39 | Ice chips or ice water | During infusion of chemotherapy |
Variable | Modified Oral Mucositis Assessment scorec |
Autologous=1.6 Allogeneic=3.7 |
4.3 11.6 |
Gori39 | 2007 | Yes | 62/60 | Ice chips | At least 60 min once methotrexate infusion started |
Methotrexate | CTC, Grade 3-4 | 47% | 53% |
Bhatt34 | 2010 | No | 12/13 (historical cohort) |
Ice chips | 30 min prior to until infusion complete |
Mel | CTC, Grade 3 | 17% | 38% |
Svanberg38 | 2010 | Yes | 39/39 | Ice chips or cold water | During infusion of chemotherapy |
Variable | WHO, Grade 3-4 | 36% | 62% |
Mel = melphalan; BEAM = carmustine, etoposide, cytarabine, and melphalan; TBI = total body irradiation; Flu = fludarabine; WHO = World Health Organization; CTC = Common Toxicity Criteria.
Other - included total body irradiation vs. craniospinal irradiation vs. high-dose cytarabine.
Study compared two different total durations of oral cryotherapy, 60 min (n=17) and 120 min (n=18).
Based on modified Oral Mucositis Assessment Score; Autologous group (n=62) index ranged 0-5; Allogeneic group (n=16) index ranged 0-16.